Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs. standard-dose ribavirin in chronic hepatitis C genotype 3
NCT00830609Phase 4Completed
- Start
- Nov 2008
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ribavirin in hepatitis C (HCV). Started Nov 2008; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00830609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830609.